VC FundEIF
🇪🇺 Biogeneration Capital Fund IV C.V.
Biogeneration IV Management B.V. · Multi-Country
Focus
Health & Bio
EIF sector
Life Science
About Biogeneration Capital Fund IV C.V.
BioGeneration Capital Fund IV is an early-stage life sciences fund managed by BioGeneration Ventures, a Naarden-based investor in European biopharma and therapeutic innovation. The fund closed at EUR 140 million and is backed by the European Investment Fund alongside investors including Eli Lilly, Novo Holdings and KfW Capital.
EUACC IntelligenceFree preview
EUACC Intelligence
Ask about Biogeneration Capital Fund IV C.V.
Get instant answers about Biogeneration Capital Fund IV C.V. and how it fits your raise.